chr6-31962685-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_006929.5(SKIC2):c.1212-29G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.154 in 1,607,370 control chromosomes in the GnomAD database, including 19,940 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as not provided (no stars).
Frequency
Genomes: 𝑓 0.16 ( 2093 hom., cov: 31)
Exomes 𝑓: 0.15 ( 17847 hom. )
Consequence
SKIC2
NM_006929.5 intron
NM_006929.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.34
Publications
150 publications found
Genes affected
SKIC2 (HGNC:10898): (SKI2 subunit of superkiller complex) DEAD box proteins, characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD), are putative RNA helicases. They are implicated in a number of cellular processes involving alteration of RNA secondary structure such as translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. Based on their distribution patterns, some members of this family are believed to be involved in embryogenesis, spermatogenesis, and cellular growth and division. This gene encodes a DEAD box protein, which is a human homologue of yeast SKI2 and may be involved in antiviral activity by blocking translation of poly(A) deficient mRNAs. This gene is located in the class III region of the major histocompatibility complex. [provided by RefSeq, Jul 2008]
SKIC2 Gene-Disease associations (from GenCC):
- trichohepatoenteric syndrome 2Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P
- trichohepatoenteric syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.213 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SKIC2 | NM_006929.5 | c.1212-29G>A | intron_variant | Intron 11 of 27 | ENST00000375394.7 | NP_008860.4 | ||
| SKIC2 | XM_011514815.4 | c.1212-29G>A | intron_variant | Intron 11 of 24 | XP_011513117.1 | |||
| SKIC2 | XM_047419259.1 | c.1212-29G>A | intron_variant | Intron 11 of 24 | XP_047275215.1 | |||
| SKIC2 | XM_047419260.1 | c.1212-29G>A | intron_variant | Intron 11 of 23 | XP_047275216.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.161 AC: 24462AN: 151900Hom.: 2093 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
24462
AN:
151900
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.143 AC: 35468AN: 248358 AF XY: 0.148 show subpopulations
GnomAD2 exomes
AF:
AC:
35468
AN:
248358
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.153 AC: 222530AN: 1455352Hom.: 17847 Cov.: 31 AF XY: 0.154 AC XY: 111637AN XY: 724432 show subpopulations
GnomAD4 exome
AF:
AC:
222530
AN:
1455352
Hom.:
Cov.:
31
AF XY:
AC XY:
111637
AN XY:
724432
show subpopulations
African (AFR)
AF:
AC:
7146
AN:
33342
American (AMR)
AF:
AC:
4625
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
AC:
2482
AN:
26092
East Asian (EAS)
AF:
AC:
3765
AN:
39668
South Asian (SAS)
AF:
AC:
18048
AN:
86122
European-Finnish (FIN)
AF:
AC:
6330
AN:
52646
Middle Eastern (MID)
AF:
AC:
582
AN:
5756
European-Non Finnish (NFE)
AF:
AC:
169780
AN:
1106810
Other (OTH)
AF:
AC:
9772
AN:
60210
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
10530
21061
31591
42122
52652
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
6222
12444
18666
24888
31110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.161 AC: 24489AN: 152018Hom.: 2093 Cov.: 31 AF XY: 0.159 AC XY: 11810AN XY: 74310 show subpopulations
GnomAD4 genome
AF:
AC:
24489
AN:
152018
Hom.:
Cov.:
31
AF XY:
AC XY:
11810
AN XY:
74310
show subpopulations
African (AFR)
AF:
AC:
8975
AN:
41422
American (AMR)
AF:
AC:
2038
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
334
AN:
3468
East Asian (EAS)
AF:
AC:
433
AN:
5160
South Asian (SAS)
AF:
AC:
941
AN:
4814
European-Finnish (FIN)
AF:
AC:
1196
AN:
10580
Middle Eastern (MID)
AF:
AC:
35
AN:
292
European-Non Finnish (NFE)
AF:
AC:
10132
AN:
67986
Other (OTH)
AF:
AC:
350
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1026
2052
3079
4105
5131
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
258
516
774
1032
1290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
689
AN:
3478
ClinVar
Significance: not provided
Submissions summary: Other:1
Revision: no classification provided
LINK: link
Submissions by phenotype
not provided Other:1
-
Department of Ophthalmology and Visual Sciences Kyoto University
Significance:not provided
Review Status:no classification provided
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.